Marvell Technology Posts Upbeat Sales, Joins MongoDB, Intel, MINISO Group And Other Big Stocks Moving Higher On Friday - Marvell Technology (NASDAQ:MRVL)

U.S. stocks were higher, with the Nasdaq Composite gaining around 150 points on Friday.

Shares of Marvell Technology, Inc. (NASDAQ:MRVL) rose during Friday's session after the company reported better-than-expected quarterly sales results.

Marvell reported quarterly GAAP earnings of 30 cents per share, in-line with the analyst consensus estimate. Quarterly sales came in at $1.27 billion, which beat the analyst consensus estimate by 1.65%.

Marvell Technology shares gained 6.1% to $74.09 on Friday.

Here are some other big stocks recording gains in today's session.

Now Read This:

‘This Is A Very Speculative Situation,’ Jim Cramer On ADMA Biologics

Market News and Data brought to you by Benzinga APIs

To add Benzinga News as your preferred source on Google, click here.

U.S. stocks were higher, with the Nasdaq Composite gaining around 150 points on Friday.

Shares of Marvell Technology, Inc. (NASDAQ:MRVL) rose during Friday's session after the company reported better-than-expected quarterly sales results.

Marvell Technology shares gained 6.1% to $74.09 on Friday.

Here are some other big stocks recording gains in today's session.

Leslie’s, Inc. (NASDAQ:LESL) shares jumped 18.2% to $2.9552.
MongoDB, Inc. (NASDAQ:MDB) gained 15.8% to $284.62 after the company reported better-than-expected second-quarter financial results and issued strong guidance on Thursday.
Intuitive Machines, Inc. (NASDAQ:LUNR) jumped 15.3% to $5.56 after the company was awarded a $116.9 million NASA contract to deliver six science and technology payloads to the Moon.
Polestar Automotive Holding UK PLC (NASDAQ:PSNY) gained 10.7% to $1.1850. Cantor Fitzgerald analyst Andres Sheppard reiterated Polestar Automotive with an Overweight and maintained a $3 price target.
BridgeBio Pharma, Inc. (NASDAQ:BBIO) gained 10.1% to $27.09 in reaction to Alnylam Pharmaceuticals’ detailed data from HELIOS-B Phase 3 study of vutrisiran. BridgeBio Pharma has ATTR-CM therapy acoramidis, currently under FDA priority review with an action date of November 29.
Cool Company Ltd. (NYSE:CLCO) rose 9.6% to $12.06. Cool Co recently reported better-than-expected quarterly sales.
ZEEKR Intelligent Technology Holding Limited (NYSE:ZK) gained 8.3% to $17.54.
Highest Performances Holdings Inc. (NASDAQ:HPH) rose 7.9% to $1.9638.
Titan Machinery Inc. (NASDAQ:TITN) gained 7.9% to $15.36.
Intel Corporation (NASDAQ:INTC) rose 7.8% to $21.70 following a report suggesting the company is weighing options including splitting its product design and manufacturing businesses.
Banco Macro S.A. (NYSE:BMA) gained 7.8% to $60.07. JP Morgan analyst Domingos Falavina upgraded Banco Macro from Underweight to Neutral and raised the price target from $14 to $78.
MINISO Group Holding Limited (NYSE:MNSO) gained 5.5% to $17.23 after the company reported fourth-quarter financial results and announced a share repurchase program of HK$2 billion.
Frontline plc (NYSE:FRO) gained 4.6% to $24.41 following strong quarterly sales.
Autodesk, Inc. (NASDAQ:ADSK) rose 4% to $268.33 as the company posted better-than-expected second-quarter EPS and revenues on Thursday.
CrowdStrike Holdings, Inc. (NASDAQ:CRWD) gained 4% to $282.45. HSBC analyst Stephen Bersey upgraded CrowdStrike from Hold to Buy and raised the price target from $302 to $339.